Industry Expert in Regulatory Sciences and Commercial Strategy Joins New Service Organization Focused on Helping Life Science Companies Develop and Commercialize Next-Generation Medical Products
(Bethesda, MD) April 8, 2013 – Precision for Medicine, Inc., (“Precision”) today announced that Karen Becker, PhD, has joined the company’s leadership team and will help life science companies capitalize on next-generation approaches to product development and commercialization.
Dr. Becker has been named Managing Director. Prior to her appointment at Precision, Dr. Becker served as the CEO of Becker and Associates, a company she founded and built into one of the premier regulatory strategy firms for the biopharmaceutical and medical device industries.
“We are very pleased to have Karen Becker join our team,” said Precision co-founder, Mark P. Clein. “Dr. Becker is one of the most well respected regulatory experts in our industry. She brings a unique combination of device and drug knowledge and offers unparalleled insight into the divisions of the US Food and Drug Administration (FDA) that review and approve marketing applications for these products.”
“This is an exciting time to be working with life science companies and the FDA,” said Dr. Becker. “The entire development and commercialization lifecycle for drugs, devices, and diagnostics is evolving and, in many cases, programs that were traditionally independent will become more integrated and co-dependent. This creates a new set of interesting challenges for regulators working to keep pace with innovation.”
About Precision for Medicine
Precision for Medicine is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD.